Advances and challenges of nanoparticle-based macrophage reprogramming for cancer immunotherapy

KS Kapitanova, VA Naumenko, AS Garanina… - Biochemistry …, 2019 - Springer
Despite the progress of modern medicine, oncological diseases are still among the most
common causes of death of adult populations in developed countries. The current …

[HTML][HTML] Micro and nano material carriers for immunomodulation

E Bracho-Sanchez, CQ Xia, MJ Clare-Salzler… - American Journal of …, 2016 - Elsevier
Modulation of the immune system through the use of micro and nano carriers offers
opportunities in transplant tolerance, autoimmunity, infectious disease, and cancer. In …

Delivery of liposome-encapsulated drugs to macrophages

CR Alving - Pharmacology & therapeutics, 1983 - Elsevier
Many investigators have proposed that liposomes be utilized as carriers to deliver drugs.
One perceived difficulty in this approach has been that liposomes are cleared rapidly by …

Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery

H Wang, Y Liu, R He, D Xu, J Zang… - Biomaterials …, 2020 - pubs.rsc.org
Nanoparticle capture and elimination by the immune system are great obstacles for drug
delivery. Camouflaging nanoparticles with cell membrane represents a promising strategy to …

The application of high-content analysis in the study of targeted particulate delivery systems for intracellular drug delivery to alveolar macrophages

C Lawlor, MP O'Sullivan, N Sivadas… - Molecular …, 2011 - ACS Publications
With an ever increasing number of particulate drug delivery systems being developed for the
intracellular delivery of therapeutics a robust high-throughput method for studying particle …

Cell-bound nanoparticles for tissue targeting and immunotherapy: Engineering of the particle–membrane interface

S Prakash, N Kumbhojkar, JR Clegg… - Current Opinion in Colloid …, 2021 - Elsevier
Nanoparticles (NPs) have been developed as vehicles for delivering a variety of payloads
including small molecules, nucleic acids, and proteins. To overcome the non-specific …

Endocytosis of particle formulations by macrophages and its application to clinical treatment

K Hirota, H Terada - Molecular regulation of endocytosis, 2012 - books.google.com
Macrophages are known to take up “invaders” such as pathogens and viruses mainly by
phagocytosis to protect the host from infections by them. This process of phagocytosis is …

[引用][C] Particle engineering of biodegradable colloids for site-specific drug delivery

PD Scholes, AGA Coombes, MC Davies, L Illum… - Controlled Drug Delivery …, 1997

Macrophage-associated disorders: pathophysiology, treatment challenges, and possible solutions

K Yadav, M Pradhan, D Singh, MR Singh - Macrophage Targeted Delivery …, 2022 - Springer
Immune disorders are a self-attacking state of our defense mechanism influencing diverse
body tissues and organs. One of the most significant obstacles in treatment for immune …

[HTML][HTML] Engineering nanoparticles to overcome immunological barriers for enhanced drug delivery

T Malachowski, A Hassel - Engineered Regeneration, 2020 - Elsevier
Nanotechnology has recently gained traction in the medical field as a method of targeted
delivery and timed release of therapeutic drugs. As interest in this field grows, design …